Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.891
https://www.valueinhealthjournal.com/article/S1098-3015(17)31225-1/fulltext
Title :
Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31225-1&doi=10.1016/j.jval.2017.08.891
First page :
A555
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
850